| HOME >> BIOLOGY >> TECHNOLOGY |
(11,603,614) (12,489,285)
Net change in non-cash working capital balances 615,806 (1,552,485)
-------------------------------------------------------------------------
Cash used in operating activities (10,987,808) (14,041,770)
-------------------------------------------------------------------------
INVESTING ACTIVITIES
Payment relating to acquisition of net assets - (123,120)
Acquisition of short-term investments (11,000,548) -
Proceeds from maturity of short-term investments 1,500,548 -
Government incentives received on account of
property, plant and equipment 30,224 54,422
Proceeds on disposal of property, plant and
equipment 4,786 11,888
Proceeds from sale (purchase) of investment 3,196,200 (1,740,146)
Selling costs incurred for sale of investment
and future royalty stream (100,000) -
Proceeds from sale of right to future royalty
stream 3,652,800 -
Purchase of property, plant and equipment (623,520) (1,000,017)
-------------------------------------------------------------------------
Cash used in investing activities (3,339,510) (2,796,973)
-------------------------------------------------------------------------
FINANCING ACTIVITIES
Proceeds from bridge loan - 8,681,250
Proceeds from units issued 17,500,000 1,102,993
Proceeds from over-allotment warrants issued 22,500 -
Proceeds from exercise of compensation warrants 23,730 -
Proceeds from exercise of stock opti
'/>"/>
| SOURCE Bioniche Life Sciences Inc. Copyright©2007 PR Newswire. All rights reserved |